ADIG vs. IBT, FJV, ASLI, BGUK, JUSC, JMI, MNL, BSV, IAT, and CGL
Should you be buying abrdn Diversified Income & Growth stock or one of its competitors? The main competitors of abrdn Diversified Income & Growth include International Biotechnology (IBT), Fidelity Japan Trust (FJV), abrdn European Logistics Income (ASLI), Baillie Gifford UK Growth Trust (BGUK), JPMorgan US Smaller Companies Investment Trust (JUSC), JPMorgan UK Smaller Companies Investment Trust (JMI), Manchester & London Investment Trust (MNL), British Smaller Companies VCT (BSV), Invesco Asia Trust (IAT), and Castelnau Group (CGL). These companies are all part of the "asset management" industry.
abrdn Diversified Income & Growth (LON:ADIG) and International Biotechnology (LON:IBT) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.
32.7% of abrdn Diversified Income & Growth shares are owned by institutional investors. Comparatively, 52.1% of International Biotechnology shares are owned by institutional investors. 2.2% of abrdn Diversified Income & Growth shares are owned by insiders. Comparatively, 4.7% of International Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
International Biotechnology has a net margin of 84.61% compared to abrdn Diversified Income & Growth's net margin of -94.25%. International Biotechnology's return on equity of 15.33% beat abrdn Diversified Income & Growth's return on equity.
International Biotechnology received 60 more outperform votes than abrdn Diversified Income & Growth when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 67.26% of users gave abrdn Diversified Income & Growth an outperform vote.
abrdn Diversified Income & Growth has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, International Biotechnology has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500.
abrdn Diversified Income & Growth pays an annual dividend of GBX 6 per share and has a dividend yield of 7.8%. International Biotechnology pays an annual dividend of GBX 28 per share and has a dividend yield of 4.4%. abrdn Diversified Income & Growth pays out -30,000.0% of its earnings in the form of a dividend. International Biotechnology pays out 2,666.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. abrdn Diversified Income & Growth is clearly the better dividend stock, given its higher yield and lower payout ratio.
International Biotechnology has higher revenue and earnings than abrdn Diversified Income & Growth. abrdn Diversified Income & Growth is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.
In the previous week, abrdn Diversified Income & Growth and abrdn Diversified Income & Growth both had 1 articles in the media. International Biotechnology's average media sentiment score of 0.67 beat abrdn Diversified Income & Growth's score of 0.64 indicating that International Biotechnology is being referred to more favorably in the news media.
Summary
International Biotechnology beats abrdn Diversified Income & Growth on 12 of the 16 factors compared between the two stocks.
Get abrdn Diversified Income & Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for ADIG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ADIG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
abrdn Diversified Income & Growth Competitors List
Related Companies and Tools
